Rhythm Pharmaceuticals (RYTM) PT Raised to $120 at Guggenheim
Tweet
Share
E-mailGet Alerts RYTM Hot Sheet
Price: $107.17 -4.76%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Guggenheim analyst Seamus Fernandez raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $120.00 (from $119.00) while maintaining a Buy rating.
You May Also Be Interested In
- Deutsche Bank Starts Rhythm Pharmaceuticals (RYTM) at Hold
- Minimax Group Inc (100:HK) PT Raised to HK$804 at Macquarie
- Freedom Broker Downgrades Workday (WDAY) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
